← Evidence map

ReviewCurrent oncology reports2017

Cabozantinib: an Active Novel Multikinase Inhibitor in Renal Cell Carcinoma.

Nizar M Tannir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

26 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 28247252